Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1999-01-22
2000-02-29
Jordan, Kimberly
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514284, 514824, A61K 3144
Patent
active
060309792
ABSTRACT:
The present invention provides a pharmaceutical composition comprising 5,6-dihydrodibenzo[a,g]quinolizinium derivative and the salts thereof of formula (I) which specifically inhibits the sterol 14-reductase which is involved in the distal pathway of cholesterol biosynthesis, and the use of the compound of formula (I) for treating hypercholesterolaemia or hyperlipidaemia. ##STR1##
REFERENCES:
patent: 3835140 (1974-09-01), Zee-Cheng et al.
patent: 4033966 (1977-07-01), Sawa
patent: 4042592 (1977-08-01), Sawa
patent: 4087426 (1978-05-01), Shamma et al.
patent: 4200629 (1980-04-01), Nakamura
patent: 4761417 (1988-08-01), Maroko
patent: 4761477 (1988-08-01), Ikekawa et al.
patent: 4980344 (1990-12-01), Maroko
Fukuda et al., Chem. Pharm. Bull., vol. 18, No. 7, p. 1299-1304 (1970).
Naruto et al., Tetrahedron Lett., vol. 19, p. 1597-1600 (1976).
Karas-Gasparec et al., CA Accession No. 1968:46980 (1968).
Jhong Tae Neung
Kim Eui Deok
Kim Jung Ho
Kim Seung Un
Lee You Suk
Hanwha Corporation
Jordan Kimberly
LandOfFree
Pharmaceutical composition comprising 5,6-dihydrodibenzo[A,G] Qu does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pharmaceutical composition comprising 5,6-dihydrodibenzo[A,G] Qu, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising 5,6-dihydrodibenzo[A,G] Qu will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-683312